The Dual Antiplatelet Therapy Study (DAPT Study)

Completed · Phase 4 · Has a placebo group

Conditions studied: Coronary Artery Disease

In brief

The DAPT Study is a double blind randomized controlled trial intended to determine the appropriate duration for dual antiplatelet therapy (the combination of aspirin and a second anti-clotting medication) as well as the safety and effectiveness of dual antiplatelet therapy to protect patients from stent thrombosis and major adverse cardiovascular and cerebrovascular events (MACCE) following the implantation of drug-eluting coronary stents. Similar analysis will be conducted in a smaller cohort of bare metal coronary stent - treated subjects.

Key facts

Study ID
NCT00977938
Run by
Baim Institute for Clinical Research
People needed
25682
Starts
2009-10-01
Expected to finish
2014-06-01
Last updated by the study team
2017-06-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.